| Home | Contacts | Sitemap | |||||
![]() ![]() |
![]() |
||||||
|
Press Release For Immediate Release Delmarva Foundation to Monitor New Medicare Easton, Maryland, November 21, 2005 - The Medicare Prescription Drug benefit is being implemented by the Centers for Medicare and Medicaid Services (CMS) to allow all Medicare beneficiaries access to prescription drug coverage beginning on January 1, 2006. Marketing began on October 1, 2005 and Enrollment of the new benefit begins on November 15, 2005 to allow beneficiaries to choose from a variety of plans, including private prescription drug plans that offer drug-only coverage, or Medicare Advantage plans that offer both prescription drug and health care coverage. Delmarva Foundation will be responsible for monitoring for fraud, waste, or abuse in the new Medicare Prescription Drug benefit program. Delmarva will have the work performed by its wholly owned subsidiary Health Integrity, LLC Health Integrity has been authorized by CMS to monitor the new prescription drug program and to investigate any beneficiary complaints related to the Medicare prescription drug benefit. Health Integrity is interested in receiving reports of potential fraud, waste or abuse from Medicare beneficiaries. Examples of these types of complaints may include:
Please contact us at 1(877)7SafeRx -1(877)772-3379 to report complaints about one of these types of fraud, waste, and abuse issues or a related complaint. Our fax number is (410) 819-8698 and our website is www.healthintegrity.org. If you have a general question or concern related to your Medicare drug benefit and it is not a potential fraud, waste or abuse issue please contact your Plan or call 1-800-MEDICARE. |
||||||